The significance of 5-hmC loss specifically in cancer cells became further evident when reintroduction of the 5-hmC by recombinant IDH2 or TET2, suppressed tumor growth and increased tumor-free survival in the melanoma mouse models [26]. The gene discussed is IDH2; the disease is melanoma.